IN RE: Doxycycline Patent-Antitrust Litigation

~. Case MDL No. 274 Document 2 Filed 05/11/15 Page 1 of 2
JUDICIAL PANEL ON.
MULTIDISTRICT LITIGATION
LED
DOCKET NO. 274
DEC 30 1976
BEFORE THE JUDICIAL PANEL ON MULTIDISTRICT LETRGATION. , oy
CLERK	OF THE PAKEL
IN RE DOXYCYCLINE PATENT-ANTITRUST LITIGATION
TRANSFER ORDER
It appearing that all parties to the actions listed on the
attached Schedule A either agree on the desirability of or do not
oppose transfer of the action pending in the District of Minnesota
to the Central District of California for coordinated or consolidated
pretrial proceedings pursuant to 28 U.S.C. §1407 with the action
pending in that district before the Honorable Martin Pence, sitting
by designation under 28 U.S.C. §292(b), and the Panel having
found upon consideration of the papers submitted that these actions
involve common questions of fact and that transfer will serve the
convenience of the parties and witnesses and promote the just and
efficient conduct of this litigation, '
IT IS ORDERED that the action listed on the attached Schedule A
and pending in the District of Minnesota be, and the same hereby is,
transferred to the Central District of California and, with the
consent of that court, assigned to the Honorable Martin Pence, sitting
by designation under 28 U.S.C. §292(b), for coordinated or
consolidated pretrial proceedings pursuant to 28 U.S.C. §1407
with the action pending in that district and listed on Schedule A.
FOR THE PANEL:
<= 6 Moot iS
"John	Minor wisdom
Chairman
1/ A second action filed in the Central District of California was
also included in the motion before the Panel but has since been
dismissed. Thus, the question of its transfer under Section 1407
has become moot.

EE Case MDL No. 274 Document 2 Filed 05/11/15 Page 2 of 2
DOCKET NO. 274
SCHEDULE A
E€ENTRAL DISTRICT OF CALIFORNIA
Pfizer Inc. v. International Rectifier Civil Action
Corp., et al. No. 73-58
DISTRICT OF MINNESOTA
American Medical Centers, Inc. v. Pfizer Civil Action
No. 4-75-562